Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | CTSK | P43235 | 9/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.36 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL66399 | 0.84 | CA2 (0.42) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL66398 | 0.84 | CA2 (0.42) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL29696200 | 0.84 | CA2 (0.42) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL8460619 | 0.79 | GRIK1 (0.41) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL31407436 | 0.79 | GRIK1 (0.41) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL25177958 | 0.78 | GRIK1 (0.43) | CA2SLC1A2SLC1A1MEN1KMT2A | |
| SCHEMBL6078689 | 0.77 | AAK1 (0.38) | CA2SLC1A2SLC1A3CTSKCTSS | |
| SCHEMBL15876012 | 0.76 | CA2 (0.35) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL2595589 | 0.76 | CA2 (0.35) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL7027023 | 0.75 | CA2 (0.45) | CA2MAPK1SLC1A2SLC1A1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1105416-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF EXOCHELINS | Keystone Biomedical, Inc. (US) | 2001-06-13 | — | — | EP | claimed |
| WO-2000009547-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF EXOCHELINS | KEYSTONE BIOMEDICAL, INC. (US) | 2000-02-24 | — | — | WO | claimed |
| EP-1105416-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF EXOCHELINS | Keystone Biomedical, Inc. (US) | 2001-06-13 | — | — | EP | disclosed |
| WO-2000009547-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF EXOCHELINS | KEYSTONE BIOMEDICAL, INC. (US) | 2000-02-24 | — | — | WO | disclosed |